Helping Canadians address the challenges of living with asthma and allergic disease is at the core of AllerGen’s integrated research strategy.

Led by internationally recognized Canadian researchers with expertise across almost 50 disciplines, the Network’s research projects and strategic initiatives employ multidisciplinary, cross-sectoral approaches to accelerate the development of new diagnostic tests, better medications, accessible patient education tools and effective public policies relevant to allergic disease.

Following the successful renewal of its federal NCE (Networks of Centres of Excellence Program) funding in 2012, AllerGen entered its second and final seven-year NCE funding cycle with mature and globally-connected research teams; a balanced portfolio across investments in discovery, development, commercialization and knowledge mobilization; and an integrated research strategy spanning three Enabling Platforms and three Legacy Projects that build upon core research investments established in 2005.